Latest Distribution Agreements News

Memphasys delivered a record $150,000 quarterly revenue, secured its largest Felix™ supply contract with Monash IVF, and expanded into UK and Southeast Asian IVF markets, positioning for accelerated growth in FY27.

First Graphene has signed an MOU with Sixth Element to distribute its PureGRAPH® CEM additive across China, with potential for local manufacturing via a joint venture once sales milestones are met.

Associate Global Partners has partnered with US investment manager ARK to bring the ARK Venture Fund to Australian wholesale investors, expanding AGP's access to high-growth private companies focused on technological disruption.

Memphasys has locked in a three-year exclusive distribution agreement for its Felix™ sperm separation system in Thailand, targeting a key IVF market with 110 clinics and 20,000–30,000 cycles annually. The deal adds approximately A$430,500 in contracted revenue, lifting South-East Asian minimum contracts to about A$1 million and contributing to FY2026 Felix™ sales now exceeding A$3 million.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.

Sprintex Limited has locked in underwriting agreements covering 8.7 million unexercised options, potentially raising up to A$870,000. The company also agreed to extend a A$1.85 million convertible note maturity by one year, pending shareholder approval.

Sprintex has landed a three-year exclusive distribution agreement in Taiwan with Shing Yu, including a paid trial at TSMC’s wastewater facilities aiming to cut energy use by half.

Stealth Group Holdings has posted record preliminary FY26 results, driven by strong organic growth and the transformative acquisition of Hardware & Building Traders (HBT). The company remains on track for its ambitious FY28 sales and EBITDA margin targets.

Echo IQ has partnered with Mayo Clinic to assess its AI platform's ability to predict heart failure risk in patients undergoing cancer therapy, targeting the growing cardio-oncology sector.

icetana AI has expanded its strategic partnership with SoftBank Robotics Group by signing a distribution agreement with SoftBank Robotics America, marking its entry into one of the world's largest security technology markets.

ReNerve Limited has appointed UG Medical to distribute its NervAlign nerve repair products in Malaysia, tapping into a fast-growing healthcare market backed by government investment.

Me Today Limited’s China partner has increased its ownership in the Me Today China trademark to 40% after hitting key revenue targets, reflecting growing traction in the Chinese sports nutrition market.